在怀孕期间导航糖尿病:减轻风险和改善母亲和孩子的结果的关键方法
Zoe Paige Garvey1, Abhishek Gupta1, Nicole Taylor1
1Molecular Cardiology and Angiogenesis Laboratory, Department of Surgery, University of Connecticut School of Medicine, Farmington, CT 06030, USA.
Metabolites
|March 26, 2025
概括
在怀孕期间控制糖尿病至关重要. 生活方式干预和向药物治疗的结合,以及持续的葡萄糖监测和远程医疗,改善了母亲和胎儿的健康结果.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 怀孕期间的糖尿病对母亲和胎儿的健康都有很大的风险.
- 随着患病率的增加,孕期糖尿病 (GDM) 和已经存在的糖尿病需要有效的管理策略.
研究的目的:
- 审查在怀孕期间胰岛素抵抗的病理生理学.
- 概述与糖尿病怀孕相关的不良结果.
- 评估当前的管理策略,包括生活方式干预和药物治疗.
主要方法:
- 关于糖尿病在怀孕管理中的当前文献的综述.
- 分析生活方式干预措施 (饮食,运动,教育,自我监测).
- 对药物治疗 (胰岛素,类似物,抗高血糖药) 和新兴技术 (CGM,远程医疗) 的评估.
主要成果:
- 生活方式干预在管理和预防GDM方面表现有前途.
- 药物治疗有效地实现血糖控制并改善结果.
- 结合生活方式和药物治疗提供了最大的好处.
- 持续的葡萄糖监测和远程医疗改善了管理.
结论:
- 早期生活方式干预和向药物治疗的综合方法对在怀孕期间管理糖尿病最有好处.
- 未来的研究应该专注于新型抗高血糖药物,改进远程医疗和加强孕前护理.
- 解决这些问题可以减少对母亲和胎儿的不良后果.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
833
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
833
Diabetes: Management and Pharmacotherapy
216
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
216
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
494
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
494
Oral Hypoglycemic Agents: Biguanides and Glitazones
144
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
144


